Repare Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview

Repare Therapeutics

02/05/2023 03:07

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 3
(estimated). 
    * The St-laurent Quebec-based  company is expected to report
 a
1,400.0% increase in revenue to $6.12 million from $408 thousand
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Repare Therapeutics
Inc
is for a loss of 81 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $28​, above​ its last closing price
of $9.21. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.70       -0.72      -0.75     Missed  -3.9
 Sep. 30 2022  -0.89       -0.89      1.71      Beat    292.6
 Jun. 30 2022  -0.84       -0.85      -0.91     Missed  -7.5​
 Mar. 31 2022  -0.86       -0.86      -0.83     Beat    3
 ​​Dec.        -0.74       -0.74      -0.70     Beat    5.4
 31 2021                                                
 Sep. 30 2021  -0.71       -0.71      -0.83     Missed  -16.9​
 Jun. 30 2021  -0.60       -0.60      -0.71     Missed  -17.4
 Mar. 31 2021  -0.51       -0.51      -0.58     Missed  -14.6
 This summary was machine generated May 2 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated